Recent advances in medical treatment of uterine fibroids

Heba M. Eltoukhi, Ayman Al-Hendy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Uterine fibroids (leiomyomas) are the most common benign gynecologic tumor. Common presentation includes abnormal uterine bleeding, pelvic pain, pressure symptoms, reduced fertility and obstetric complication. Steroids play a key role in the pathogenesis of UF by enhancing the expression of autocrine/paracrine growth factors, cytokines and chemokines, which results in the proliferation and deregulation of the extracellular matrix of leiomyoma cells. Generally, hysterectomy is the only definitive treatment available, however this intervention is oftentimes, not an optimal solution for women of child-bearing age as it eliminates the chance for future pregnancies. In recent years, several medical strategies have evolved in the treatment of uterine fibroids including e.g., hormonal agents e.g., GnRH analogs, Levonorgestrel intrauterine system, selective progesterone receptor modulators, selective estrogen receptor modulators, Aromatase inhibitor and other therapeutics such as All-trans retinoic acid, TGF-β receptor inhibitors, EGF receptor inhibitors, Catechol-O-methyl transferase inhibitor, Vit D, Green Tea Extracts, Halofuginone, Genistein and Curcumin.... Although surgery is the most effective treatment for uterine leiomyoma, other medical options have been investigated and show promising results. More research is needed to evaluate the short and long term efficacy of these novel approaches.

Original languageEnglish (US)
Title of host publicationLeiomyomas
Subtitle of host publicationRisk Factors, Clinical Manifestations and Treatment Options
PublisherNova Science Publishers, Inc.
Pages125-149
Number of pages25
ISBN (Electronic)9781634636032
ISBN (Print)9781634635844
StatePublished - Jan 1 2015

Fingerprint

obstetrics
deregulation
physician's care
proliferation
surgery
pain
pregnancy
fertility

Keywords

  • Inhibitors
  • Medical treatment
  • Modulators
  • Receptor
  • Uterine leiomyoma

ASJC Scopus subject areas

  • Social Sciences(all)

Cite this

Eltoukhi, H. M., & Al-Hendy, A. (2015). Recent advances in medical treatment of uterine fibroids. In Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options (pp. 125-149). Nova Science Publishers, Inc..

Recent advances in medical treatment of uterine fibroids. / Eltoukhi, Heba M.; Al-Hendy, Ayman.

Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc., 2015. p. 125-149.

Research output: Chapter in Book/Report/Conference proceedingChapter

Eltoukhi, HM & Al-Hendy, A 2015, Recent advances in medical treatment of uterine fibroids. in Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc., pp. 125-149.
Eltoukhi HM, Al-Hendy A. Recent advances in medical treatment of uterine fibroids. In Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc. 2015. p. 125-149
Eltoukhi, Heba M. ; Al-Hendy, Ayman. / Recent advances in medical treatment of uterine fibroids. Leiomyomas: Risk Factors, Clinical Manifestations and Treatment Options. Nova Science Publishers, Inc., 2015. pp. 125-149
@inbook{29d19b7c23e74132ab9abe2e075eb7ae,
title = "Recent advances in medical treatment of uterine fibroids",
abstract = "Uterine fibroids (leiomyomas) are the most common benign gynecologic tumor. Common presentation includes abnormal uterine bleeding, pelvic pain, pressure symptoms, reduced fertility and obstetric complication. Steroids play a key role in the pathogenesis of UF by enhancing the expression of autocrine/paracrine growth factors, cytokines and chemokines, which results in the proliferation and deregulation of the extracellular matrix of leiomyoma cells. Generally, hysterectomy is the only definitive treatment available, however this intervention is oftentimes, not an optimal solution for women of child-bearing age as it eliminates the chance for future pregnancies. In recent years, several medical strategies have evolved in the treatment of uterine fibroids including e.g., hormonal agents e.g., GnRH analogs, Levonorgestrel intrauterine system, selective progesterone receptor modulators, selective estrogen receptor modulators, Aromatase inhibitor and other therapeutics such as All-trans retinoic acid, TGF-β receptor inhibitors, EGF receptor inhibitors, Catechol-O-methyl transferase inhibitor, Vit D, Green Tea Extracts, Halofuginone, Genistein and Curcumin.... Although surgery is the most effective treatment for uterine leiomyoma, other medical options have been investigated and show promising results. More research is needed to evaluate the short and long term efficacy of these novel approaches.",
keywords = "Inhibitors, Medical treatment, Modulators, Receptor, Uterine leiomyoma",
author = "Eltoukhi, {Heba M.} and Ayman Al-Hendy",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781634635844",
pages = "125--149",
booktitle = "Leiomyomas",
publisher = "Nova Science Publishers, Inc.",
address = "United States",

}

TY - CHAP

T1 - Recent advances in medical treatment of uterine fibroids

AU - Eltoukhi, Heba M.

AU - Al-Hendy, Ayman

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Uterine fibroids (leiomyomas) are the most common benign gynecologic tumor. Common presentation includes abnormal uterine bleeding, pelvic pain, pressure symptoms, reduced fertility and obstetric complication. Steroids play a key role in the pathogenesis of UF by enhancing the expression of autocrine/paracrine growth factors, cytokines and chemokines, which results in the proliferation and deregulation of the extracellular matrix of leiomyoma cells. Generally, hysterectomy is the only definitive treatment available, however this intervention is oftentimes, not an optimal solution for women of child-bearing age as it eliminates the chance for future pregnancies. In recent years, several medical strategies have evolved in the treatment of uterine fibroids including e.g., hormonal agents e.g., GnRH analogs, Levonorgestrel intrauterine system, selective progesterone receptor modulators, selective estrogen receptor modulators, Aromatase inhibitor and other therapeutics such as All-trans retinoic acid, TGF-β receptor inhibitors, EGF receptor inhibitors, Catechol-O-methyl transferase inhibitor, Vit D, Green Tea Extracts, Halofuginone, Genistein and Curcumin.... Although surgery is the most effective treatment for uterine leiomyoma, other medical options have been investigated and show promising results. More research is needed to evaluate the short and long term efficacy of these novel approaches.

AB - Uterine fibroids (leiomyomas) are the most common benign gynecologic tumor. Common presentation includes abnormal uterine bleeding, pelvic pain, pressure symptoms, reduced fertility and obstetric complication. Steroids play a key role in the pathogenesis of UF by enhancing the expression of autocrine/paracrine growth factors, cytokines and chemokines, which results in the proliferation and deregulation of the extracellular matrix of leiomyoma cells. Generally, hysterectomy is the only definitive treatment available, however this intervention is oftentimes, not an optimal solution for women of child-bearing age as it eliminates the chance for future pregnancies. In recent years, several medical strategies have evolved in the treatment of uterine fibroids including e.g., hormonal agents e.g., GnRH analogs, Levonorgestrel intrauterine system, selective progesterone receptor modulators, selective estrogen receptor modulators, Aromatase inhibitor and other therapeutics such as All-trans retinoic acid, TGF-β receptor inhibitors, EGF receptor inhibitors, Catechol-O-methyl transferase inhibitor, Vit D, Green Tea Extracts, Halofuginone, Genistein and Curcumin.... Although surgery is the most effective treatment for uterine leiomyoma, other medical options have been investigated and show promising results. More research is needed to evaluate the short and long term efficacy of these novel approaches.

KW - Inhibitors

KW - Medical treatment

KW - Modulators

KW - Receptor

KW - Uterine leiomyoma

UR - http://www.scopus.com/inward/record.url?scp=84955699102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955699102&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84955699102

SN - 9781634635844

SP - 125

EP - 149

BT - Leiomyomas

PB - Nova Science Publishers, Inc.

ER -